Research programme: neuro-oncology therapeutics - Voyager Therapeutics
Alternative Names: monoclonal antibodies - Voyager TherapeuticsLatest Information Update: 03 Nov 2021
At a glance
- Originator Voyager Therapeutics
- Class Antineoplastics; Gene therapies; Monoclonal antibodies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research CNS cancer
Most Recent Events
- 21 Oct 2021 Early research in CNS cancer in USA (Parenteral)(Voyager Therapeutics website, October 2021)